30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q14 Revenue: TiGenix

ChondroCelect €1.3MM (~US $1.8MM), +26%

  • Licensed ChondroCelect marketing and distribution to Sobi for Europe, Turkey, Russia, Middle East and North Africa
  • Sold Dutch manufacturing facility to PharmaCell